Skip to main content
. 2020 Mar 18;12(3):716. doi: 10.3390/cancers12030716

Table 2.

Description of publicly available human proteomic studies used in the proteome meta-analysis.

Ref. Sample Labeling Technique Validation Method
[6] PTT CD nanoLC-ESI-MS/MS IHC
[60] PTT CD MALDI-TOF MS, nanoLC-ESI MS/MS -
[61] PTT Free MALDI-TOF/TOF MS, MS/MS IHC
[62] PTT Free MS/MS WB
[63] PTT Free MS/MS WB, IHC
[64] PTT Free LC-MS/MS ELISA
[65] PTT Free LC-MS/MS ELISA
[66] PTT Free MS/MS -
[67] PTT Free LC-MS/MS IHC
[68] PTT Free MALDI-TOF MS ELISA
[69] PTT Free LC-MS/MS IHC
[70] PTT Free MALDI-TOF MS IHC, WB
[71] PTT CD MALDI-TOF/TOF-MS WB, IHC
[72] PTT Free MALDI-TOF MS WB
[73] PTT Free MALDI-TOF/TOF-MS -
[29] PTT Free LC-MS/MS IHC, WB
[74] PTT Free LC-MS/MS -
[75] PTT SI LC-MS/MS -
[76] PTT Free LC-MS/MS IHC, WB
[77] PTT LP MS/MS -
[78] PTT Free LC-MS(MS)2 -
[79] PTT Free UHPLC/MS/MS2 -
[80] Urine CD MALDI-TOF MS IB
[81] Serum Free MALDI-QIT-TOF-MS
[82] Serum Free (MRM) WB
[83] Serum Free MS/MS -
[84] Blood Free MALDI-MS ELISA
[85] Serum CD MALDI-TOF/ TOF–MS ELISA, WB
[86] Serum IL LC-MS / MS -
[87] Urine Free LC/MS /MS -
[88] Plasma Free LC−MS/MS ELISA, WB, IHC, RT-qPCR
[89] PDF Free GeLC-MS/MS -
[90] Serum Free MALDI-TOF MS PCR, WB, IHC
[91] PJ Free MALDI-TOF MS MS/MS WB, IHC, ELISA
[92] Serum Free MALDI-TOF WB

Ref.: Reference; PDF: Pancreatic duct fluid, PJ: Pancreatic juice; PTT: Pancreatic tumor tissue; SI: Stable Isotopic; IL: Isobaric Label; CD: CyDyes (Fluorescence Cyanine Dyes); LC-MS/MS: Liquid chromatography-tandem mass spectrometry; LC-MRM/MS: Multiplexed liquid chromatography multiple-reaction-monitoring mass spectrometry; Nano-RPLC-MS/MS: Nanoscale liquid chromatography coupled to tandem mass spectrometry; ESI-MS/MS: Electrospray ionization mass spectrometry; MALDI-TOF MS: Laser desorption ionization-time of flight mass spectrometry; MS/MS: Tandem mass spectrometry; MRM: Multiple Reaction Monitoring; IHC: Immunohistochemistry; WB: Western Blot; IB: Immunoblotting.